Wire Stories
Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
BEIJING–(BUSINESS WIRE)–#Antibody–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announces an antibody evaluation and option agreement with Gilead Sciences, Inc. The...